Global Cholera Vaccines Oral Live Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cholera Vaccines Oral Live market size was valued at US$ 83 million in 2023. With growing demand in downstream market, the Cholera Vaccines Oral Live is forecast to a readjusted size of US$ 135.7 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Cholera Vaccines Oral Live market. Cholera Vaccines Oral Live are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cholera Vaccines Oral Live. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cholera Vaccines Oral Live market.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Key Features:
The report on Cholera Vaccines Oral Live market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cholera Vaccines Oral Live market. It may include historical data, market segmentation by Type (e.g., Euvichol- Plus, DUKORAL), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cholera Vaccines Oral Live market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cholera Vaccines Oral Live market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cholera Vaccines Oral Live industry. This include advancements in Cholera Vaccines Oral Live technology, Cholera Vaccines Oral Live new entrants, Cholera Vaccines Oral Live new investment, and other innovations that are shaping the future of Cholera Vaccines Oral Live.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cholera Vaccines Oral Live market. It includes factors influencing customer ' purchasing decisions, preferences for Cholera Vaccines Oral Live product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cholera Vaccines Oral Live market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cholera Vaccines Oral Live market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cholera Vaccines Oral Live market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cholera Vaccines Oral Live industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cholera Vaccines Oral Live market.
Market Segmentation:
Cholera Vaccines Oral Live market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Cholera Vaccines Oral Live market?
What factors are driving Cholera Vaccines Oral Live market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cholera Vaccines Oral Live market opportunities vary by end market size?
How does Cholera Vaccines Oral Live break out type, application?
According to our LPI (LP Information) latest study, the global Cholera Vaccines Oral Live market size was valued at US$ 83 million in 2023. With growing demand in downstream market, the Cholera Vaccines Oral Live is forecast to a readjusted size of US$ 135.7 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Cholera Vaccines Oral Live market. Cholera Vaccines Oral Live are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cholera Vaccines Oral Live. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cholera Vaccines Oral Live market.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Key Features:
The report on Cholera Vaccines Oral Live market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cholera Vaccines Oral Live market. It may include historical data, market segmentation by Type (e.g., Euvichol- Plus, DUKORAL), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cholera Vaccines Oral Live market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cholera Vaccines Oral Live market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cholera Vaccines Oral Live industry. This include advancements in Cholera Vaccines Oral Live technology, Cholera Vaccines Oral Live new entrants, Cholera Vaccines Oral Live new investment, and other innovations that are shaping the future of Cholera Vaccines Oral Live.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cholera Vaccines Oral Live market. It includes factors influencing customer ' purchasing decisions, preferences for Cholera Vaccines Oral Live product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cholera Vaccines Oral Live market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cholera Vaccines Oral Live market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cholera Vaccines Oral Live market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cholera Vaccines Oral Live industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cholera Vaccines Oral Live market.
Market Segmentation:
Cholera Vaccines Oral Live market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Euvichol- Plus
- DUKORAL
- Shanchol
- Others
- Prevention
- Emergency Response
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PaxVax
- Sanofi
- Valneva
- EuBiologics
- Shanghai United Cell Biotechnology
- Vabiotech
What is the 10-year outlook for the global Cholera Vaccines Oral Live market?
What factors are driving Cholera Vaccines Oral Live market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cholera Vaccines Oral Live market opportunities vary by end market size?
How does Cholera Vaccines Oral Live break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cholera Vaccines Oral Live Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Cholera Vaccines Oral Live by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Cholera Vaccines Oral Live by Country/Region, 2019, 2023 & 2030
2.2 Cholera Vaccines Oral Live Segment by Type
2.2.1 Euvichol- Plus
2.2.2 DUKORAL
2.2.3 Shanchol
2.2.4 Others
2.3 Cholera Vaccines Oral Live Sales by Type
2.3.1 Global Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
2.3.2 Global Cholera Vaccines Oral Live Revenue and Market Share by Type (2019-2024)
2.3.3 Global Cholera Vaccines Oral Live Sale Price by Type (2019-2024)
2.4 Cholera Vaccines Oral Live Segment by Application
2.4.1 Prevention
2.4.2 Emergency Response
2.5 Cholera Vaccines Oral Live Sales by Application
2.5.1 Global Cholera Vaccines Oral Live Sale Market Share by Application (2019-2024)
2.5.2 Global Cholera Vaccines Oral Live Revenue and Market Share by Application (2019-2024)
2.5.3 Global Cholera Vaccines Oral Live Sale Price by Application (2019-2024)
3 GLOBAL CHOLERA VACCINES ORAL LIVE BY COMPANY
3.1 Global Cholera Vaccines Oral Live Breakdown Data by Company
3.1.1 Global Cholera Vaccines Oral Live Annual Sales by Company (2019-2024)
3.1.2 Global Cholera Vaccines Oral Live Sales Market Share by Company (2019-2024)
3.2 Global Cholera Vaccines Oral Live Annual Revenue by Company (2019-2024)
3.2.1 Global Cholera Vaccines Oral Live Revenue by Company (2019-2024)
3.2.2 Global Cholera Vaccines Oral Live Revenue Market Share by Company (2019-2024)
3.3 Global Cholera Vaccines Oral Live Sale Price by Company
3.4 Key Manufacturers Cholera Vaccines Oral Live Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cholera Vaccines Oral Live Product Location Distribution
3.4.2 Players Cholera Vaccines Oral Live Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHOLERA VACCINES ORAL LIVE BY GEOGRAPHIC REGION
4.1 World Historic Cholera Vaccines Oral Live Market Size by Geographic Region (2019-2024)
4.1.1 Global Cholera Vaccines Oral Live Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Cholera Vaccines Oral Live Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Cholera Vaccines Oral Live Market Size by Country/Region (2019-2024)
4.2.1 Global Cholera Vaccines Oral Live Annual Sales by Country/Region (2019-2024)
4.2.2 Global Cholera Vaccines Oral Live Annual Revenue by Country/Region (2019-2024)
4.3 Americas Cholera Vaccines Oral Live Sales Growth
4.4 APAC Cholera Vaccines Oral Live Sales Growth
4.5 Europe Cholera Vaccines Oral Live Sales Growth
4.6 Middle East & Africa Cholera Vaccines Oral Live Sales Growth
5 AMERICAS
5.1 Americas Cholera Vaccines Oral Live Sales by Country
5.1.1 Americas Cholera Vaccines Oral Live Sales by Country (2019-2024)
5.1.2 Americas Cholera Vaccines Oral Live Revenue by Country (2019-2024)
5.2 Americas Cholera Vaccines Oral Live Sales by Type
5.3 Americas Cholera Vaccines Oral Live Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cholera Vaccines Oral Live Sales by Region
6.1.1 APAC Cholera Vaccines Oral Live Sales by Region (2019-2024)
6.1.2 APAC Cholera Vaccines Oral Live Revenue by Region (2019-2024)
6.2 APAC Cholera Vaccines Oral Live Sales by Type
6.3 APAC Cholera Vaccines Oral Live Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cholera Vaccines Oral Live by Country
7.1.1 Europe Cholera Vaccines Oral Live Sales by Country (2019-2024)
7.1.2 Europe Cholera Vaccines Oral Live Revenue by Country (2019-2024)
7.2 Europe Cholera Vaccines Oral Live Sales by Type
7.3 Europe Cholera Vaccines Oral Live Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cholera Vaccines Oral Live by Country
8.1.1 Middle East & Africa Cholera Vaccines Oral Live Sales by Country (2019-2024)
8.1.2 Middle East & Africa Cholera Vaccines Oral Live Revenue by Country (2019-2024)
8.2 Middle East & Africa Cholera Vaccines Oral Live Sales by Type
8.3 Middle East & Africa Cholera Vaccines Oral Live Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cholera Vaccines Oral Live
10.3 Manufacturing Process Analysis of Cholera Vaccines Oral Live
10.4 Industry Chain Structure of Cholera Vaccines Oral Live
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cholera Vaccines Oral Live Distributors
11.3 Cholera Vaccines Oral Live Customer
12 WORLD FORECAST REVIEW FOR CHOLERA VACCINES ORAL LIVE BY GEOGRAPHIC REGION
12.1 Global Cholera Vaccines Oral Live Market Size Forecast by Region
12.1.1 Global Cholera Vaccines Oral Live Forecast by Region (2025-2030)
12.1.2 Global Cholera Vaccines Oral Live Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cholera Vaccines Oral Live Forecast by Type
12.7 Global Cholera Vaccines Oral Live Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 PaxVax
13.1.1 PaxVax Company Information
13.1.2 PaxVax Cholera Vaccines Oral Live Product Portfolios and Specifications
13.1.3 PaxVax Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 PaxVax Main Business Overview
13.1.5 PaxVax Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Cholera Vaccines Oral Live Product Portfolios and Specifications
13.2.3 Sanofi Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Valneva
13.3.1 Valneva Company Information
13.3.2 Valneva Cholera Vaccines Oral Live Product Portfolios and Specifications
13.3.3 Valneva Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Valneva Main Business Overview
13.3.5 Valneva Latest Developments
13.4 EuBiologics
13.4.1 EuBiologics Company Information
13.4.2 EuBiologics Cholera Vaccines Oral Live Product Portfolios and Specifications
13.4.3 EuBiologics Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 EuBiologics Main Business Overview
13.4.5 EuBiologics Latest Developments
13.5 Shanghai United Cell Biotechnology
13.5.1 Shanghai United Cell Biotechnology Company Information
13.5.2 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product Portfolios and Specifications
13.5.3 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shanghai United Cell Biotechnology Main Business Overview
13.5.5 Shanghai United Cell Biotechnology Latest Developments
13.6 Vabiotech
13.6.1 Vabiotech Company Information
13.6.2 Vabiotech Cholera Vaccines Oral Live Product Portfolios and Specifications
13.6.3 Vabiotech Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Vabiotech Main Business Overview
13.6.5 Vabiotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cholera Vaccines Oral Live Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Cholera Vaccines Oral Live by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Cholera Vaccines Oral Live by Country/Region, 2019, 2023 & 2030
2.2 Cholera Vaccines Oral Live Segment by Type
2.2.1 Euvichol- Plus
2.2.2 DUKORAL
2.2.3 Shanchol
2.2.4 Others
2.3 Cholera Vaccines Oral Live Sales by Type
2.3.1 Global Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
2.3.2 Global Cholera Vaccines Oral Live Revenue and Market Share by Type (2019-2024)
2.3.3 Global Cholera Vaccines Oral Live Sale Price by Type (2019-2024)
2.4 Cholera Vaccines Oral Live Segment by Application
2.4.1 Prevention
2.4.2 Emergency Response
2.5 Cholera Vaccines Oral Live Sales by Application
2.5.1 Global Cholera Vaccines Oral Live Sale Market Share by Application (2019-2024)
2.5.2 Global Cholera Vaccines Oral Live Revenue and Market Share by Application (2019-2024)
2.5.3 Global Cholera Vaccines Oral Live Sale Price by Application (2019-2024)
3 GLOBAL CHOLERA VACCINES ORAL LIVE BY COMPANY
3.1 Global Cholera Vaccines Oral Live Breakdown Data by Company
3.1.1 Global Cholera Vaccines Oral Live Annual Sales by Company (2019-2024)
3.1.2 Global Cholera Vaccines Oral Live Sales Market Share by Company (2019-2024)
3.2 Global Cholera Vaccines Oral Live Annual Revenue by Company (2019-2024)
3.2.1 Global Cholera Vaccines Oral Live Revenue by Company (2019-2024)
3.2.2 Global Cholera Vaccines Oral Live Revenue Market Share by Company (2019-2024)
3.3 Global Cholera Vaccines Oral Live Sale Price by Company
3.4 Key Manufacturers Cholera Vaccines Oral Live Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cholera Vaccines Oral Live Product Location Distribution
3.4.2 Players Cholera Vaccines Oral Live Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHOLERA VACCINES ORAL LIVE BY GEOGRAPHIC REGION
4.1 World Historic Cholera Vaccines Oral Live Market Size by Geographic Region (2019-2024)
4.1.1 Global Cholera Vaccines Oral Live Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Cholera Vaccines Oral Live Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Cholera Vaccines Oral Live Market Size by Country/Region (2019-2024)
4.2.1 Global Cholera Vaccines Oral Live Annual Sales by Country/Region (2019-2024)
4.2.2 Global Cholera Vaccines Oral Live Annual Revenue by Country/Region (2019-2024)
4.3 Americas Cholera Vaccines Oral Live Sales Growth
4.4 APAC Cholera Vaccines Oral Live Sales Growth
4.5 Europe Cholera Vaccines Oral Live Sales Growth
4.6 Middle East & Africa Cholera Vaccines Oral Live Sales Growth
5 AMERICAS
5.1 Americas Cholera Vaccines Oral Live Sales by Country
5.1.1 Americas Cholera Vaccines Oral Live Sales by Country (2019-2024)
5.1.2 Americas Cholera Vaccines Oral Live Revenue by Country (2019-2024)
5.2 Americas Cholera Vaccines Oral Live Sales by Type
5.3 Americas Cholera Vaccines Oral Live Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cholera Vaccines Oral Live Sales by Region
6.1.1 APAC Cholera Vaccines Oral Live Sales by Region (2019-2024)
6.1.2 APAC Cholera Vaccines Oral Live Revenue by Region (2019-2024)
6.2 APAC Cholera Vaccines Oral Live Sales by Type
6.3 APAC Cholera Vaccines Oral Live Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cholera Vaccines Oral Live by Country
7.1.1 Europe Cholera Vaccines Oral Live Sales by Country (2019-2024)
7.1.2 Europe Cholera Vaccines Oral Live Revenue by Country (2019-2024)
7.2 Europe Cholera Vaccines Oral Live Sales by Type
7.3 Europe Cholera Vaccines Oral Live Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cholera Vaccines Oral Live by Country
8.1.1 Middle East & Africa Cholera Vaccines Oral Live Sales by Country (2019-2024)
8.1.2 Middle East & Africa Cholera Vaccines Oral Live Revenue by Country (2019-2024)
8.2 Middle East & Africa Cholera Vaccines Oral Live Sales by Type
8.3 Middle East & Africa Cholera Vaccines Oral Live Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cholera Vaccines Oral Live
10.3 Manufacturing Process Analysis of Cholera Vaccines Oral Live
10.4 Industry Chain Structure of Cholera Vaccines Oral Live
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cholera Vaccines Oral Live Distributors
11.3 Cholera Vaccines Oral Live Customer
12 WORLD FORECAST REVIEW FOR CHOLERA VACCINES ORAL LIVE BY GEOGRAPHIC REGION
12.1 Global Cholera Vaccines Oral Live Market Size Forecast by Region
12.1.1 Global Cholera Vaccines Oral Live Forecast by Region (2025-2030)
12.1.2 Global Cholera Vaccines Oral Live Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cholera Vaccines Oral Live Forecast by Type
12.7 Global Cholera Vaccines Oral Live Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 PaxVax
13.1.1 PaxVax Company Information
13.1.2 PaxVax Cholera Vaccines Oral Live Product Portfolios and Specifications
13.1.3 PaxVax Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 PaxVax Main Business Overview
13.1.5 PaxVax Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Cholera Vaccines Oral Live Product Portfolios and Specifications
13.2.3 Sanofi Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Valneva
13.3.1 Valneva Company Information
13.3.2 Valneva Cholera Vaccines Oral Live Product Portfolios and Specifications
13.3.3 Valneva Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Valneva Main Business Overview
13.3.5 Valneva Latest Developments
13.4 EuBiologics
13.4.1 EuBiologics Company Information
13.4.2 EuBiologics Cholera Vaccines Oral Live Product Portfolios and Specifications
13.4.3 EuBiologics Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 EuBiologics Main Business Overview
13.4.5 EuBiologics Latest Developments
13.5 Shanghai United Cell Biotechnology
13.5.1 Shanghai United Cell Biotechnology Company Information
13.5.2 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product Portfolios and Specifications
13.5.3 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shanghai United Cell Biotechnology Main Business Overview
13.5.5 Shanghai United Cell Biotechnology Latest Developments
13.6 Vabiotech
13.6.1 Vabiotech Company Information
13.6.2 Vabiotech Cholera Vaccines Oral Live Product Portfolios and Specifications
13.6.3 Vabiotech Cholera Vaccines Oral Live Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Vabiotech Main Business Overview
13.6.5 Vabiotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cholera Vaccines Oral Live Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Cholera Vaccines Oral Live Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Euvichol- Plus
Table 4. Major Players of DUKORAL
Table 5. Major Players of Shanchol
Table 6. Major Players of Others
Table 7. Global Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 8. Global Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Table 9. Global Cholera Vaccines Oral Live Revenue by Type (2019-2024) & ($ million)
Table 10. Global Cholera Vaccines Oral Live Revenue Market Share by Type (2019-2024)
Table 11. Global Cholera Vaccines Oral Live Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 13. Global Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Table 14. Global Cholera Vaccines Oral Live Revenue by Application (2019-2024)
Table 15. Global Cholera Vaccines Oral Live Revenue Market Share by Application (2019-2024)
Table 16. Global Cholera Vaccines Oral Live Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Cholera Vaccines Oral Live Sales by Company (2019-2024) & (K Units)
Table 18. Global Cholera Vaccines Oral Live Sales Market Share by Company (2019-2024)
Table 19. Global Cholera Vaccines Oral Live Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Cholera Vaccines Oral Live Revenue Market Share by Company (2019-2024)
Table 21. Global Cholera Vaccines Oral Live Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Cholera Vaccines Oral Live Producing Area Distribution and Sales Area
Table 23. Players Cholera Vaccines Oral Live Products Offered
Table 24. Cholera Vaccines Oral Live Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Cholera Vaccines Oral Live Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Cholera Vaccines Oral Live Sales Market Share Geographic Region (2019-2024)
Table 29. Global Cholera Vaccines Oral Live Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Cholera Vaccines Oral Live Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Cholera Vaccines Oral Live Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Cholera Vaccines Oral Live Sales Market Share by Country/Region (2019-2024)
Table 33. Global Cholera Vaccines Oral Live Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Cholera Vaccines Oral Live Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Cholera Vaccines Oral Live Sales by Country (2019-2024) & (K Units)
Table 36. Americas Cholera Vaccines Oral Live Sales Market Share by Country (2019-2024)
Table 37. Americas Cholera Vaccines Oral Live Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Cholera Vaccines Oral Live Revenue Market Share by Country (2019-2024)
Table 39. Americas Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 40. Americas Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 41. APAC Cholera Vaccines Oral Live Sales by Region (2019-2024) & (K Units)
Table 42. APAC Cholera Vaccines Oral Live Sales Market Share by Region (2019-2024)
Table 43. APAC Cholera Vaccines Oral Live Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Cholera Vaccines Oral Live Revenue Market Share by Region (2019-2024)
Table 45. APAC Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 46. APAC Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 47. Europe Cholera Vaccines Oral Live Sales by Country (2019-2024) & (K Units)
Table 48. Europe Cholera Vaccines Oral Live Sales Market Share by Country (2019-2024)
Table 49. Europe Cholera Vaccines Oral Live Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Cholera Vaccines Oral Live Revenue Market Share by Country (2019-2024)
Table 51. Europe Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 52. Europe Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Cholera Vaccines Oral Live Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Cholera Vaccines Oral Live Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Cholera Vaccines Oral Live Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Cholera Vaccines Oral Live
Table 60. Key Market Challenges & Risks of Cholera Vaccines Oral Live
Table 61. Key Industry Trends of Cholera Vaccines Oral Live
Table 62. Cholera Vaccines Oral Live Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Cholera Vaccines Oral Live Distributors List
Table 65. Cholera Vaccines Oral Live Customer List
Table 66. Global Cholera Vaccines Oral Live Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Cholera Vaccines Oral Live Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Cholera Vaccines Oral Live Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Cholera Vaccines Oral Live Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Cholera Vaccines Oral Live Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Cholera Vaccines Oral Live Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Cholera Vaccines Oral Live Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Cholera Vaccines Oral Live Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Cholera Vaccines Oral Live Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Cholera Vaccines Oral Live Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Cholera Vaccines Oral Live Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Cholera Vaccines Oral Live Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Cholera Vaccines Oral Live Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Cholera Vaccines Oral Live Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. PaxVax Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 81. PaxVax Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 82. PaxVax Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. PaxVax Main Business
Table 84. PaxVax Latest Developments
Table 85. Sanofi Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 87. Sanofi Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Valneva Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 91. Valneva Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 92. Valneva Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Valneva Main Business
Table 94. Valneva Latest Developments
Table 95. EuBiologics Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 96. EuBiologics Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 97. EuBiologics Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. EuBiologics Main Business
Table 99. EuBiologics Latest Developments
Table 100. Shanghai United Cell Biotechnology Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 101. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 102. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai United Cell Biotechnology Main Business
Table 104. Shanghai United Cell Biotechnology Latest Developments
Table 105. Vabiotech Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 106. Vabiotech Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 107. Vabiotech Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Vabiotech Main Business
Table 109. Vabiotech Latest Developments
Table 1. Cholera Vaccines Oral Live Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Cholera Vaccines Oral Live Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Euvichol- Plus
Table 4. Major Players of DUKORAL
Table 5. Major Players of Shanchol
Table 6. Major Players of Others
Table 7. Global Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 8. Global Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Table 9. Global Cholera Vaccines Oral Live Revenue by Type (2019-2024) & ($ million)
Table 10. Global Cholera Vaccines Oral Live Revenue Market Share by Type (2019-2024)
Table 11. Global Cholera Vaccines Oral Live Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 13. Global Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Table 14. Global Cholera Vaccines Oral Live Revenue by Application (2019-2024)
Table 15. Global Cholera Vaccines Oral Live Revenue Market Share by Application (2019-2024)
Table 16. Global Cholera Vaccines Oral Live Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Cholera Vaccines Oral Live Sales by Company (2019-2024) & (K Units)
Table 18. Global Cholera Vaccines Oral Live Sales Market Share by Company (2019-2024)
Table 19. Global Cholera Vaccines Oral Live Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Cholera Vaccines Oral Live Revenue Market Share by Company (2019-2024)
Table 21. Global Cholera Vaccines Oral Live Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Cholera Vaccines Oral Live Producing Area Distribution and Sales Area
Table 23. Players Cholera Vaccines Oral Live Products Offered
Table 24. Cholera Vaccines Oral Live Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Cholera Vaccines Oral Live Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Cholera Vaccines Oral Live Sales Market Share Geographic Region (2019-2024)
Table 29. Global Cholera Vaccines Oral Live Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Cholera Vaccines Oral Live Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Cholera Vaccines Oral Live Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Cholera Vaccines Oral Live Sales Market Share by Country/Region (2019-2024)
Table 33. Global Cholera Vaccines Oral Live Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Cholera Vaccines Oral Live Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Cholera Vaccines Oral Live Sales by Country (2019-2024) & (K Units)
Table 36. Americas Cholera Vaccines Oral Live Sales Market Share by Country (2019-2024)
Table 37. Americas Cholera Vaccines Oral Live Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Cholera Vaccines Oral Live Revenue Market Share by Country (2019-2024)
Table 39. Americas Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 40. Americas Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 41. APAC Cholera Vaccines Oral Live Sales by Region (2019-2024) & (K Units)
Table 42. APAC Cholera Vaccines Oral Live Sales Market Share by Region (2019-2024)
Table 43. APAC Cholera Vaccines Oral Live Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Cholera Vaccines Oral Live Revenue Market Share by Region (2019-2024)
Table 45. APAC Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 46. APAC Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 47. Europe Cholera Vaccines Oral Live Sales by Country (2019-2024) & (K Units)
Table 48. Europe Cholera Vaccines Oral Live Sales Market Share by Country (2019-2024)
Table 49. Europe Cholera Vaccines Oral Live Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Cholera Vaccines Oral Live Revenue Market Share by Country (2019-2024)
Table 51. Europe Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 52. Europe Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Cholera Vaccines Oral Live Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Cholera Vaccines Oral Live Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Cholera Vaccines Oral Live Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Cholera Vaccines Oral Live Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Cholera Vaccines Oral Live Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Cholera Vaccines Oral Live
Table 60. Key Market Challenges & Risks of Cholera Vaccines Oral Live
Table 61. Key Industry Trends of Cholera Vaccines Oral Live
Table 62. Cholera Vaccines Oral Live Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Cholera Vaccines Oral Live Distributors List
Table 65. Cholera Vaccines Oral Live Customer List
Table 66. Global Cholera Vaccines Oral Live Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Cholera Vaccines Oral Live Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Cholera Vaccines Oral Live Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Cholera Vaccines Oral Live Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Cholera Vaccines Oral Live Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Cholera Vaccines Oral Live Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Cholera Vaccines Oral Live Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Cholera Vaccines Oral Live Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Cholera Vaccines Oral Live Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Cholera Vaccines Oral Live Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Cholera Vaccines Oral Live Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Cholera Vaccines Oral Live Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Cholera Vaccines Oral Live Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Cholera Vaccines Oral Live Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. PaxVax Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 81. PaxVax Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 82. PaxVax Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. PaxVax Main Business
Table 84. PaxVax Latest Developments
Table 85. Sanofi Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 87. Sanofi Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Valneva Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 91. Valneva Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 92. Valneva Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Valneva Main Business
Table 94. Valneva Latest Developments
Table 95. EuBiologics Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 96. EuBiologics Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 97. EuBiologics Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. EuBiologics Main Business
Table 99. EuBiologics Latest Developments
Table 100. Shanghai United Cell Biotechnology Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 101. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 102. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai United Cell Biotechnology Main Business
Table 104. Shanghai United Cell Biotechnology Latest Developments
Table 105. Vabiotech Basic Information, Cholera Vaccines Oral Live Manufacturing Base, Sales Area and Its Competitors
Table 106. Vabiotech Cholera Vaccines Oral Live Product Portfolios and Specifications
Table 107. Vabiotech Cholera Vaccines Oral Live Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Vabiotech Main Business
Table 109. Vabiotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cholera Vaccines Oral Live
Figure 2. Cholera Vaccines Oral Live Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cholera Vaccines Oral Live Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Cholera Vaccines Oral Live Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Cholera Vaccines Oral Live Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Euvichol- Plus
Figure 10. Product Picture of DUKORAL
Figure 11. Product Picture of Shanchol
Figure 12. Product Picture of Others
Figure 13. Global Cholera Vaccines Oral Live Sales Market Share by Type in 2023
Figure 14. Global Cholera Vaccines Oral Live Revenue Market Share by Type (2019-2024)
Figure 15. Cholera Vaccines Oral Live Consumed in Prevention
Figure 16. Global Cholera Vaccines Oral Live Market: Prevention (2019-2024) & (K Units)
Figure 17. Cholera Vaccines Oral Live Consumed in Emergency Response
Figure 18. Global Cholera Vaccines Oral Live Market: Emergency Response (2019-2024) & (K Units)
Figure 19. Global Cholera Vaccines Oral Live Sales Market Share by Application (2023)
Figure 20. Global Cholera Vaccines Oral Live Revenue Market Share by Application in 2023
Figure 21. Cholera Vaccines Oral Live Sales Market by Company in 2023 (K Units)
Figure 22. Global Cholera Vaccines Oral Live Sales Market Share by Company in 2023
Figure 23. Cholera Vaccines Oral Live Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Cholera Vaccines Oral Live Revenue Market Share by Company in 2023
Figure 25. Global Cholera Vaccines Oral Live Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Cholera Vaccines Oral Live Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 28. Americas Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 29. APAC Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 30. APAC Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 31. Europe Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 32. Europe Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 35. Americas Cholera Vaccines Oral Live Sales Market Share by Country in 2023
Figure 36. Americas Cholera Vaccines Oral Live Revenue Market Share by Country in 2023
Figure 37. Americas Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 38. Americas Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 39. United States Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Cholera Vaccines Oral Live Sales Market Share by Region in 2023
Figure 44. APAC Cholera Vaccines Oral Live Revenue Market Share by Regions in 2023
Figure 45. APAC Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 46. APAC Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 47. China Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Cholera Vaccines Oral Live Sales Market Share by Country in 2023
Figure 55. Europe Cholera Vaccines Oral Live Revenue Market Share by Country in 2023
Figure 56. Europe Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 57. Europe Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 58. Germany Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Cholera Vaccines Oral Live Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 67. Egypt Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Cholera Vaccines Oral Live in 2023
Figure 73. Manufacturing Process Analysis of Cholera Vaccines Oral Live
Figure 74. Industry Chain Structure of Cholera Vaccines Oral Live
Figure 75. Channels of Distribution
Figure 76. Global Cholera Vaccines Oral Live Sales Market Forecast by Region (2025-2030)
Figure 77. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Cholera Vaccines Oral Live Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Cholera Vaccines Oral Live Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Cholera Vaccines Oral Live
Figure 2. Cholera Vaccines Oral Live Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cholera Vaccines Oral Live Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Cholera Vaccines Oral Live Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Cholera Vaccines Oral Live Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Euvichol- Plus
Figure 10. Product Picture of DUKORAL
Figure 11. Product Picture of Shanchol
Figure 12. Product Picture of Others
Figure 13. Global Cholera Vaccines Oral Live Sales Market Share by Type in 2023
Figure 14. Global Cholera Vaccines Oral Live Revenue Market Share by Type (2019-2024)
Figure 15. Cholera Vaccines Oral Live Consumed in Prevention
Figure 16. Global Cholera Vaccines Oral Live Market: Prevention (2019-2024) & (K Units)
Figure 17. Cholera Vaccines Oral Live Consumed in Emergency Response
Figure 18. Global Cholera Vaccines Oral Live Market: Emergency Response (2019-2024) & (K Units)
Figure 19. Global Cholera Vaccines Oral Live Sales Market Share by Application (2023)
Figure 20. Global Cholera Vaccines Oral Live Revenue Market Share by Application in 2023
Figure 21. Cholera Vaccines Oral Live Sales Market by Company in 2023 (K Units)
Figure 22. Global Cholera Vaccines Oral Live Sales Market Share by Company in 2023
Figure 23. Cholera Vaccines Oral Live Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Cholera Vaccines Oral Live Revenue Market Share by Company in 2023
Figure 25. Global Cholera Vaccines Oral Live Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Cholera Vaccines Oral Live Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 28. Americas Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 29. APAC Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 30. APAC Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 31. Europe Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 32. Europe Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Cholera Vaccines Oral Live Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Cholera Vaccines Oral Live Revenue 2019-2024 ($ Millions)
Figure 35. Americas Cholera Vaccines Oral Live Sales Market Share by Country in 2023
Figure 36. Americas Cholera Vaccines Oral Live Revenue Market Share by Country in 2023
Figure 37. Americas Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 38. Americas Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 39. United States Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Cholera Vaccines Oral Live Sales Market Share by Region in 2023
Figure 44. APAC Cholera Vaccines Oral Live Revenue Market Share by Regions in 2023
Figure 45. APAC Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 46. APAC Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 47. China Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Cholera Vaccines Oral Live Sales Market Share by Country in 2023
Figure 55. Europe Cholera Vaccines Oral Live Revenue Market Share by Country in 2023
Figure 56. Europe Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 57. Europe Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 58. Germany Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Cholera Vaccines Oral Live Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Cholera Vaccines Oral Live Sales Market Share by Application (2019-2024)
Figure 67. Egypt Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Cholera Vaccines Oral Live Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Cholera Vaccines Oral Live in 2023
Figure 73. Manufacturing Process Analysis of Cholera Vaccines Oral Live
Figure 74. Industry Chain Structure of Cholera Vaccines Oral Live
Figure 75. Channels of Distribution
Figure 76. Global Cholera Vaccines Oral Live Sales Market Forecast by Region (2025-2030)
Figure 77. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Cholera Vaccines Oral Live Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Cholera Vaccines Oral Live Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Stem Cell Therapy Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
99 pages
Global Anesthetic Gas Scavenging System (AGSS) Market Growth 2024-2030
US$ 3,660.00
August 2024
130 pages
Global PCR Test Tubes Market Growth 2024-2030
US$ 3,660.00
September 2024
120 pages
Global Rapid AIDS Test Market Growth 2024-2030
US$ 3,660.00
June 2024
109 pages
Global Tibsovo Market Growth 2024-2030
US$ 3,660.00
March 2024
76 pages
